Mineralys Therapeutics, Inc. (MLYS)

NASDAQ: MLYS · Real-Time Price · USD

43.56

+0.59 (1.37%)

Oct 17, 2025, 4:00 PM EDT - Market closed

Mineralys Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct '25 Oct 17, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	3,379	613	354	-	-	-
Market Cap Growth	430.86%	73.31%	-	-	-	-
Enterprise Value	3,054	349	100	-	-	-
Last Close Price	43.56	12.31	8.60	-	-	-
PB Ratio	9.13	3.20	1.47	-	-	-
P/TBV Ratio	10.78	3.20	1.47	-	-	-
Debt / Equity Ratio	-	-	-	-	-	-1.25
Quick Ratio	14.65	13.53	22.57	13.65	2.10	0.28
Current Ratio	15.12	14.02	23.77	13.98	2.20	0.29
Return on Equity (ROE)	-63.21%	-82.24%	-41.38%	-53.00%	-1568.96%	-
Return on Assets (ROA)	-38.80%	-52.56%	-28.91%	-31.34%	-185.60%	-
Return on Capital (ROIC)	-42.05%	-55.62%	-30.45%	-34.99%	-335.62%	-
Earnings Yield	-5.65%	-29.02%	-20.34%	-	-	-
FCF Yield	-5.70%	-27.16%	-22.96%	-	-	-
Buyback Yield / Dilution	-25.20%	-34.13%	-600.33%	-3.67%	-7.64%	-

Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q